{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:31:55Z","timestamp":1776447115871,"version":"3.51.2"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,5,10]]},"DOI":"10.18632\/oncotarget.3605","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T06:34:56Z","timestamp":1442298896000},"page":"11357-11368","source":"Crossref","is-referenced-by-count":14,"title":["Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone"],"prefix":"10.18632","volume":"6","author":[{"given":"Shigeru","family":"Kawabata","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Christine","family":"Hollander","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA"},{"name":"Present address: Laboratory of Cancer Biology and Genetics, CCR, NCI, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeva P.","family":"Munasinghe","sequence":"additional","affiliation":[{"name":"Mouse Imaging Facility, National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren R.","family":"Brinster","sequence":"additional","affiliation":[{"name":"Division of Veterinary Resources, NIH, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Mercado-Matos","sequence":"additional","affiliation":[{"name":"Medical Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Regales","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Pao","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasi A.","family":"J\u00e4nne","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Kin","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Butman","sequence":"additional","affiliation":[{"name":"Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell R.","family":"Lonser","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, NINDS, NIH, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlan R.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Gurgel","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander O.","family":"Vortmeyer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip A.","family":"Dennis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"1","first-page":"329","volume-title":"World Health Organization Classification of Tumours Pathology and Genetics of Head and Neck Tumours","author":"Sidransky","year":"2005"},{"issue":"11","key":"2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/1097-0142(19891201)64:11<2292::AID-CNCR2820641119>3.0.CO;2-#","article-title":"Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases","volume":"64","author":"Heffner","year":"1989","journal-title":"Cancer"},{"issue":"7","key":"3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/014556130808700708","article-title":"Aggressive papillary tumor of the middle ear: a true entity or an endolymphatic sac neoplasm?","volume":"87","author":"Michaels","year":"2008","journal-title":"Ear Nose Throat J"},{"issue":"21","key":"4","first-page":"5963","article-title":"Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors","volume":"60","author":"Zhuang","year":"2000","journal-title":"Cancer Res"},{"issue":"11","key":"5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1053\/hupa.2001.28961","article-title":"Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor","volume":"32","author":"Okada","year":"2001","journal-title":"Hum Pathol"},{"issue":"1","key":"6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.298.1.41","article-title":"Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease","volume":"298","author":"Lonser","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00125480-199611000-00047","article-title":"Endolymphatic Sac Tumors: Fact or Fiction?","volume":"3","author":"Heffner","year":"1996","journal-title":"Advances in Anatomic Pathology"},{"issue":"1","key":"8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2001-12783","article-title":"Papillary tumor of the temporal bone","volume":"11","author":"Draf","year":"2001","journal-title":"Skull Base"},{"issue":"1","key":"9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/S0022215109990442","article-title":"An unusual middle-ear mass","volume":"124","author":"Wilkins","year":"2010","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/lary.23646","article-title":"Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications","volume":"123","author":"Lonser","year":"2013","journal-title":"Laryngoscope"},{"issue":"11","key":"11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Chmielecki","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"5687","key":"12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.1101637","article-title":"Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways","volume":"305","author":"Settleman","year":"2004","journal-title":"Science"},{"issue":"6","key":"13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.celrep.2014.05.039","article-title":"Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M","volume":"7","author":"Dennis","year":"2014","journal-title":"Cell Rep"},{"issue":"10","key":"14","first-page":"3000","article-title":"Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer","volume":"119","author":"Pao","year":"2009","journal-title":"J Clin Invest"},{"issue":"7276","key":"15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nature08622","article-title":"Novel mutant-selective EGFR kinase inhibitors against EGFR T790M","volume":"462","author":"Janne","year":"2009","journal-title":"Nature"},{"issue":"1","key":"16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1013986627504","article-title":"Conditional gene expression in the respiratory epithelium of the mouse","volume":"11","author":"Whitsett","year":"2002","journal-title":"Transgenic Res"},{"issue":"16","key":"17","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1074\/jbc.275.16.11858","article-title":"Conditional expression of fibroblast growth factor-7 in the developing and mature lung","volume":"275","author":"Whitsett","year":"2000","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"d751","DOI":"10.2741\/1062","article-title":"Regulation of lung surfactant protein gene expression","volume":"8","author":"Boggaram","year":"2003","journal-title":"Front Biosci"},{"issue":"10","key":"19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/000348949910801001","article-title":"Surfactant protein A in rabbit sinus and middle ear mucosa","volume":"108","author":"Snyder","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"17","key":"20","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1158\/0008-5472.CAN-08-4205","article-title":"Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice","volume":"69","author":"Kiura","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Salomon","year":"2006","journal-title":"Gene"},{"issue":"8","key":"22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: at last, cancer therapy meets systems biology","volume":"12","author":"Pines","year":"2012","journal-title":"Nature Reviews Cancer"},{"issue":"5","key":"23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-013-1101-1","article-title":"EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis","volume":"125","author":"Vintermyr","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"45","key":"24","doi-asserted-by":"crossref","first-page":"44966","DOI":"10.1074\/jbc.M305502200","article-title":"Hypoxia inducible factor activates the transforming growth factor-alpha\/epidermal growth factor receptor growth stimulatory pathway in VHL(\u2212\/\u2212) renal cell carcinoma cells","volume":"278","author":"Lee","year":"2003","journal-title":"J Biol Chem"},{"issue":"12","key":"25","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1158\/0008-5472.CAN-05-0169","article-title":"Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL\u2212\/\u2212 renal cancer","volume":"65","author":"Lee","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1634\/theoncologist.2008-0124","article-title":"Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignancies","volume":"14","author":"Ettinger","year":"2009","journal-title":"Oncologist"},{"key":"27","article-title":"Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations","author":"Pao","year":"2014","journal-title":"Cancer Discov"},{"issue":"8","key":"28","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1371\/journal.pone.0000810","article-title":"Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors","volume":"2","author":"Pao","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"29","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/carcin\/bgi190","article-title":"Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model","volume":"26","author":"Miller","year":"2005","journal-title":"Carcinogenesis"},{"issue":"11","key":"30","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1101\/gad.1417406","article-title":"Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors","volume":"20","author":"Varmus","year":"2006","journal-title":"Genes Dev"},{"issue":"4","key":"31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.18632\/oncotarget.1760","article-title":"Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer","volume":"5","author":"Dennis","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"32","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Varmus","year":"2005","journal-title":"PLoS Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T15:13:18Z","timestamp":1594825998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,5,10]]}},"alternative-id":["3605","26027747"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3605","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,15]]}}}